INFLUENCE OF INTERLEUKIN-12 (IL-12) ON MINIMAL RESIDUAL DISEASE (MRD) OF MULTIPLE MYELOMA PATIENTS TREATED WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION: EXPERIENCE FROM A SINGLE BONE MARROW TRANSPLANT SERVICE AF Callera; ES Rosa; F Callera;

USE OF INTERMEDIATE-DOSE CYTARABINE PLUS G-CSF AS PERIPHERAL BLOOD STEM CELL MOBILIZATION PROTOCOL IN 311 PATIENTS WITH ONCO-HEMATOLOGICAL DISEASES: RESULTS FROM A SINGLE INSTITUTION AF Callera; ES Rosa; F Callera;

ACUTE LEUKEMIA OF MIXED B, T AND MYELOID PHENOTYPE WITH COMPLEX KARYOTYPE: TREATABLE DISEASE OR DEATH SENTENCE? DTK Obikawa; LA Vianna; AAM Zung; ES Rosa; F Callera;